The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of equity and acquisition

25 Sep 2009 07:00

RNS Number : 6454Z
Omega Diagnostics Group PLC
25 September 2009
 



25 September 2009 AIM: ODX

Omega Diagnostics Group PLC

("Omega or the "Company")

Issue of Equity and Acquisition

Omega, the AIM listed medical diagnostics company, is today pleased to announce that it has raised £1million before expenses (approximately £884k net of expenses) by way of a conditional placing (the "Placing") of 5,000,000 shares of 4p each in the capital of the Company ("Placing Shares") at 20 pence per share. The Placing was oversubscribed and the Company is pleased to welcome the new institutional investors to the register. The excess demand for Placing Shares has been taken up with the Company's single largest shareholder undertaking to sell his entire stake in the Company to certain of the investors under the Placing.

The proceeds of the Placing will be used partly to fund the acquisition of Co-Tek (South West) Ltd ("Co-Tek"), a company based in Devon which produces various tests for diagnosing bacterial diseases. The business assets comprise plant and machinery, fixtures and fittingsoffice equipment, debtor balances and cash. Net assets immediately prior to the acquisition were approximately £83k. The total consideration for the business and assets is £400k in cash. Omega has raised a further £600k before expenses of working capital which strengthens the balance sheet and provides an ability to react to other opportunities within the diagnostics industry to support further growthManagement expects the transaction to be earnings enhancing in the first full year of trading.

Unaudited financial accounts for the most recently available period covering ten months to 31 July 2009 show that Co-Tek achieved revenue of £188k, gross profit of £169k, EBITDA of £125k and PBT of £119kThe Company also paid a £54k dividend in the period.   Co-Tek has a profitable track record for the past four years.

The acquisition will strengthen Omega's position in the infectious disease test market and provides scope to increase volumes through the use of its broad geographic distribution network in over 100 countries.

David Evans, Chairman of the Company commented:

"We are very pleased with the support received for the Placing from existing and new shareholders for which we give thanks. We also look forward to the positive benefits we can expect from combining Co-Tek's operations with those of the Company including significantly increased channels to market for Co-Tek's products that the acquisition provides."

The Placing is conditional on, inter alia, the Placing Shares being admitted to trading on AIM ("Admission"). Application has been made to the London Stock Exchange for the Placing Shares to be admitted to trading on AIM and it is expected that admission will occur at 8.00 a.m. on 28 September 2009. The Placing Shares will, when issued, rank pari passu in all respects with the Company's existing ordinary shares. 

After admission of the Placing Shares the figure of 20,632,907 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules. 

For further enquiries please contact

Omega Diagnostics Group PLC

Tel: 01259 763 030

Andrew Shepherd, Chief Executive

Kieron Harbinson, Group Finance Director

www.omegadiagnostics.com

Cenkos Securities plc

Tel: 020 7397 8900

Nicholas Wells

Andy Roberts

Elizabeth Bowman

Walbrook PR Limited

Tel: 020 7933 8788

Ben Knowles

Paul McManus

Mob: 07900 346978

Ben.knowles@walbrookpr.com

Paul.mcmanus@walbrookpr.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUSSNRKNRKUAR
Date   Source Headline
28th Nov 201412:55 pmRNSCorrection: Director's Dealing
28th Nov 201410:35 amRNSDirector's Dealing
28th Nov 20147:00 amRNSDirector's Dealing
26th Nov 20147:00 amRNSHalf Yearly Report
24th Oct 20147:00 amRNSTrading Update and Notice of Interim Results
28th Aug 201412:39 pmRNSResult of AGM
1st Jul 20147:00 amRNSmHealth partnership in Sub-Saharan Africa
23rd Jun 20147:00 amRNSFinal Results
14th Apr 20147:00 amRNSTrading Update and Notice of Results
24th Mar 20144:34 pmRNSDirector/PDMR Shareholding
5th Mar 20142:38 pmRNSDirector/PDMR Shareholding
4th Mar 20143:07 pmRNSHolding(s) in Company
3rd Mar 201411:30 amRNSHolding(s) in Company
28th Feb 201412:42 pmRNSHolding(s) in Company
25th Feb 201411:38 amRNSGrant of Options
25th Feb 201410:06 amRNSCD4 - Grant of ARIPO Patent
24th Feb 20147:00 amRNSAllergy Development Update
24th Feb 20147:00 amRNSCD4 - UNITAID Grant Funding
21st Feb 20142:55 pmRNSHolding(s) in Company
13th Feb 20147:00 amRNSSuccessful completion of CD4 Technology Transfer
20th Dec 20137:00 amRNSCD4 Update
17th Dec 201310:27 amRNSHolding(s) in Company
27th Nov 20137:00 amRNSInterim Results
31st Oct 20137:00 amRNSCD4 Update
17th Oct 20137:00 amRNSTrading Update and Notice of Interim Results
26th Sep 20137:00 amRNSCD4 Update
28th Aug 201311:59 amRNSResult of AGM
17th Jul 201312:10 pmRNSHolding(s) in Company
15th Jul 201311:58 amRNSDirector/PDMR Shareholding
4th Jul 201311:22 amRNSGrant of Options
3rd Jul 20132:21 pmRNSHolding(s) in Company
1st Jul 20137:00 amRNSFinal Results
21st Jun 20137:00 amRNSAllergy Development Update
17th Jun 201310:03 amRNSHolding(s) in Company
10th Jun 201312:18 pmRNSResult of GM
24th May 20137:00 amRNSFundraising to raise £4 million
23rd Apr 20137:00 amRNSGrant of US Patent
22nd Apr 20137:00 amRNSDirectorate Change
10th Apr 20137:00 amRNSTrading Update and Notice of Results
10th Apr 20137:00 amRNSDistribution Agreement
4th Mar 20137:00 amRNSChange of Adviser
17th Dec 20127:00 amRNSChina approves Registration of Food Detective
13th Dec 20127:00 amRNSBanking Facilities increased
3rd Dec 20124:17 pmRNSHolding(s) in Company
21st Nov 20127:00 amRNSHalf Yearly Report
19th Nov 20127:00 amRNSGrant funding award
15th Oct 20127:00 amRNSAgreement with Super Religare Laboratories
15th Oct 20127:00 amRNSTrading Update & Notice of Results
28th Aug 201211:49 amRNSResult of AGM
23rd Jul 20127:00 amRNSPublication of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.